ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,399Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 315

$795K Total Retail Price of All Prescriptions

Rank: 24 out of 315

439 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 439 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

14% of this provider’s 439 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

2% of this provider’s 8,205 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$76 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
SIMVASTATIN 647 490 1 1
LISINOPRIL 417 300 2 3
AMLODIPINE BESYLATE 365 289 3 2
ATORVASTATIN CALCIUM 327 292 4 5
METFORMIN HCL ER 296 224 5 33
LOSARTAN POTASSIUM 245 218 6 4
IBUPROFEN 239 160 7 89
FENOFIBRATE 227 139 8 43
ALENDRONATE SODIUM 222 222 9 12
CRESTOR 194 174 10 24
OMEPRAZOLE 189 142 11 9
AZITHROMYCIN 159 134 12 39
CARVEDILOL 138 119 13 22
DIOVAN 138 130 13 27
LEVOTHYROXINE SODIUM 129 99 15 6
HYDROCHLOROTHIAZIDE 125 83 16 16
LOSARTAN-HYDROCHLOROTHIAZIDE 125 97 16 17
RANITIDINE HCL 120 107 18 42
ALLOPURINOL 118 91 19 14
NAMENDA 117 117 20 38
HYDROCODONE-ACETAMINOPHEN 106 56 S3 21 19
TRAMADOL HCL 103 55 22 59
NAPROXEN 102 85 23 88
WARFARIN SODIUM 102 82 23 20
TAMSULOSIN HCL 100 71 25 21
GABAPENTIN 97 55 26 37
GLIMEPIRIDE 92 59 27 32
CIPROFLOXACIN HCL 91 80 28 58
FUROSEMIDE 90 69 29 15
CLOPIDOGREL 89 78 30 25
ADVAIR DISKUS 86 71 31 46
ZOLPIDEM TARTRATE 82 70 32 29
AMLODIPINE BESYLATE-BENAZEPRIL 82 81 32 26
DIGOXIN 82 74 32 45
TRIAMCINOLONE ACETONIDE 81 67 35 62
LYRICA 79 66 36 126
CYCLOBENZAPRINE HCL 74 35 R 37 168
METFORMIN HCL 72 53 38 7
METOPROLOL SUCCINATE 72 68 38 13
LOVASTATIN 67 63 40 8
LANTUS SOLOSTAR 62 32 41 69
CEPHALEXIN 61 40 42 109
DONEPEZIL HCL 61 61 42 28
NEXIUM 61 57 42 54
NIASPAN 59 40 45 103
COLCRYS 58 55 46 85
CELEBREX 57 57 47 34
PLAVIX 55 50 48 40
GLIPIZIDE 53 30 49 30
ACTOS 53 53 49 78
HUMALOG MIX 75-25 50 39 51 205
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 13, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.